Results 241 to 250 of about 1,674,501 (287)
Some of the next articles are maybe not open access.
Ouabain Antagonists as Antihypertensive Agents
Current Pharmaceutical Design, 2005The evidence that high levels of endogenous ouabain (EO), a closely related isomer of ouabain, are implicated in human hypertension and cardiac hypertrophy and failure stimulated the pharmacological research for developing novel anti-hypertensive agents active as ouabain antagonists.
M, Ferrandi +7 more
openaire +2 more sources
Clonidine: A new antihypertensive agent
The American Journal of Cardiology, 1971Abstract Intravenous administration of clonidine in hypertensive patients resulted in a short, hypertensive response followed by a prolonged reduction of both systolic and diastolic pressure. The antihypertensive response was associated with a decrease of total forearm blood flow, while the muscle blood flow of the calf was unchanged or moderately ...
G, Onesti +4 more
openaire +2 more sources
New Antihypertensive Agents: Benefit of Treatment
Journal of Cardiovascular Pharmacology, 1992Large-scale end-point trials have demonstrated that antihypertensive treatment reverses the risk of stroke attributable to high blood pressure and probably reduces the incidence of myocardial infarction. Despite this major achievement in therapeutics, substantial goals still need to be achieved.
openaire +2 more sources
Antihypertensive Agents 1962–1968
1969Seven years ago Schlittler, Druey, and Marxer [207] reported on antihypertensive agents in a previous volume of this series. Since this review appeared, research in the field of antihypertensive drugs has made steady progress. Although spectacular breakthroughs — exemplified by such pioneering feats as the discoveries of reserpine, hydralazine ...
O, Schier, A, Marxer
openaire +2 more sources
A 1996 update on antihypertensive agents
Current Opinion in Cardiology, 1996Seven new classes of antihypertensive agents that are currently under development are outlined. Clinical studies of neutral endopeptidase inhibitors and angiotensin II receptor blockers are described. Experimental studies are described involving endothelin inhibitors, and clinical and experimental studies of a new multiple action antihypertensive agent,
openaire +2 more sources
Centrally Acting Antihypertensive Agents
Journal of Cardiovascular Pharmacology, 1988In spite of the fact that plasma catecholamine levels, baroreflex activity, and hemodynamic pattern significantly change with age and drugs whose action is mediated via the sympathetic nervous system might be expected to cause different effects, the limited available data suggest that both alpha-methyldopa and clonidine lower blood pressure to a ...
openaire +2 more sources
Renoprotection With Antihypertensive Agents
Lancet, The, 2002Johannes F E Mann, Karl F Hilgers
exaly +2 more sources

